Hydrocortisone Butyrate
Who holds supplier records for Hydrocortisone Butyrate? 3 organisations hold a current record for Hydrocortisone Butyrate: an active US FDA Type II Drug Master File. A further 4 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: Spain (1) and Israel (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Hydrocortisone Butyrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/hydrocortisone-butyrate
Reading the evidence
- 3 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (3)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Hydrocortisone Butyrate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CURIA SPAIN SAUSpain Company GMP cert on recordActive DMF 21841 · latest filing Jul 2008
- HENAN LIHUA PHARMACEUTICAL CO LTDActive DMF 31544 · latest filing Mar 2017
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 15750 · latest filing Dec 2001
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (4)
Organisations whose Type II DMFs for Hydrocortisone Butyrate are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 18142 · filed Mar 2005
- United States · Inactive DMF 10447 · filed Aug 1993
- SIPSY SNCInactive DMF 8264 · filed Nov 1989
- SOCIETA ITALIANA CORTICOSTEROIDI SPAInactive DMF 4031 · filed Dec 1980
Overview
Hydrocortisone Butyrate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1683).
Chemical identity
- IUPAC name
- [(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate
- Canonical SMILES
- CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)C(=O)CO
- InChIKey
- BMCQMVFGOVHVNG-TUFAYURCSA-N
- Synonyms
- Cortisol 17-butyrate, Hydrocortisone 17-butyrate, Hydrocortisone-17-butyrate, Hydrocortisone butyrate, Locoid, Locoid c, Locoid crelo, Locoid lipocream, NSC-758433, Hydrocortisone-17alpha-butyrate, 17-O-butyrylcortisol, H-17-B
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Corticosteroid
- Mechanism of action
- Corticosteroid Hormone Receptor Agonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Hydrocortisone Butyrate?
3 organisations hold an active US FDA Type II Drug Master File or a CEP for Hydrocortisone Butyrate: CURIA SPAIN SAU (Spain), HENAN LIHUA PHARMACEUTICAL CO LTD and Taro Pharmaceutical Industries Ltd. (Israel). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Hydrocortisone Butyrate Drug Master Files are active?
CURIA SPAIN SAU (DMF 21841), HENAN LIHUA PHARMACEUTICAL CO LTD (DMF 31544) and Taro Pharmaceutical Industries Ltd. (DMF 15750). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Hydrocortisone Butyrate records mean?
4 organisations have only inactive Type II DMFs for Hydrocortisone Butyrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Hydrocortisone Butyrate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Hydrocortisone Butyrate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.